Filing Flows › GSK (GSK) › Net income
GSK (GSK) net income by quarter
GSK's net income was $1.5B in Q3 2026 (third quarter 2026), +255% from Q2 2026. Over the last 5 quarters it ranged from $435M (Q2 2026) to $2.0B (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.5B | +255% | -23% |
| Q2 2026 | $435M | -75% | -70% |
| Q1 2026 | $1.7B | -14% | — |
| Q3 2025 | $2.0B | +40% | — |
| Q2 2025 | $1.4B | — | — |
Q3 2026 at a glance
GSK, Q3 2026: revenue $8.9B (+4% year over year), operating margin 23.9%, net earnings $1.5B, operating cash flow $3.1B. The chart follows the revenue to costs, profit and cash.
Questions
What is GSK's net income?
GSK's net income was $1.5B in Q3 2026 (third quarter 2026), +255% from Q2 2026.
How has GSK's net income changed?
Over the last 5 quarters it ranged from $435M (Q2 2026) to $2.0B (Q3 2025).